Home Blog Page 1070

First patient dosed in Gesynta Pharma’s endometriosis trial of vipoglanstat

STOCKHOLM, March 11, 2026 /PRNewswire/ — Gesynta Pharma AB today announced that the first patient has been dosed in its Phase 2 clinical proof-of-concept trial (NOVA) of vipoglanstat, a novel non-hormonal, non-opioid drug candidate for endometriosis. This milestone marks an important step toward a new treatment for the approximately 190 million women worldwide living with this painful, often debilitating, chronic inflammatory condition, which is also a major cause of infertility.

The NOVA* trial is a randomized, double-blind, placebo-controlled Phase 2 clinical proof-of-concept trial of vipoglanstat. NOVA will evaluate the efficacy and safety of two different doses of vipoglanstat compared with placebo and will also provide valuable dosing information for future clinical development.

The trial will enroll approximately 190 women aged 18 to 45 across the UK, Italy, Poland, Romania, Bulgaria, the Czech Republic, and Hungary. Participants will receive either vipoglanstat or placebo, administered orally, for approximately four menstrual cycles. The primary objective is to evaluate the efficacy of vipoglanstat on endometriosis-related pain during non-menstrual days. Secondary objectives include evaluating the effect of vipoglanstat on period pain (dysmenorrhea), pain during sexual intercourse (dyspareunia), use of opioid rescue medication, and response to a quality-of-life assessment scale. Additionally, endometriotic lesions will be evaluated as an exploratory endpoint using MRI assessments. Top-line results are expected in 2027.

“This is an important step toward expanding therapeutic options for women living with endometriosis. Despite existing treatments, many patients continue to experience persistent pain and impaired daily functioning, underscoring the need for new approaches. I am excited to work with Gesynta to assess whether vipoglanstat can deliver meaningful, lasting improvements for patients,” says Christian Becker, Professor of Reproductive Sciences, Co-Director of the Oxford Endometriosis CaRe Centre, and International Coordinating Investigator for the NOVA trial.

Vipoglanstat targets mPGES-1, a key enzyme that produces the proinflammatory mediator prostaglandin E2 (PGE2) in endometriotic lesions. A preclinical proof-of-concept study using an advanced endometriosis model showed that vipoglanstat significantly reduced pain-related behaviors and endometriotic lesion load. Previous clinical studies confirm its safety, tolerability, and pharmacodynamic effects in humans, supporting further development of vipoglanstat for endometriosis.

“Dosing the first patient in the NOVA trial signifies a major milestone in developing vipoglanstat, aiming at providing a game-changer in the treatment of endometriosis. With a solid preclinical basis and positive clinical data on safety, tolerability, and pharmacokinetics, this trial aims to provide robust, controlled data on pain relief and quality of life for women with moderate to severe disease,” says Patric Stenberg, CEO of Gesynta Pharma.

About Endometriosis
Endometriosis is a painful chronic inflammatory disorder in which endometrium-like tissue grows outside the uterus, mainly in the pelvic cavity, causing inflammation, fibrosis, and the formation of endometriotic lesions and adhesions. It commonly presents with period pain (dysmenorrhea), non-menstrual chronic pelvic pain, pain during sexual intercourse (dyspareunia) , gastrointestinal symptoms, and infertility, and is typically managed with analgesics, hormonal therapies, and surgery.

Despite its high prevalence, affecting 10% of women of reproductive age, endometriosis remains largely underdiagnosed and undertreated, with few new treatment options available to patients. The often severe pain, diagnostic challenges, and limited treatment options make endometriosis profoundly challenging to live with for many women.

*NOVA: the Non-hormonal Option – a Vipoglanstat Assessment trial

For more information, please contact: 
Patric Stenberg, CEO
Tel: + 46 (0)733 83 66 70
E-mail: patric.stenberg@gesynta.se

About Gesynta Pharma
Gesynta Pharma’s research on targeting mPGES-1, an essential enzyme in inflammation, began at Karolinska Institutet in Sweden. The company’s lead compound, vipoglanstat, a non-hormonal, non-opioid treatment, is under development for endometriosis, a chronic inflammatory condition affecting roughly 10% of women of reproductive age. Vipoglanstat significantly reduced pain-related behaviors and endometriotic lesions in an advanced preclinical disease model. The drug candidate is currently being evaluated in the Phase 2 clinical proof-of-concept trial (NOVA).

Additionally, the company’s second candidate, GS-073, is ready to enter Phase 1 clinical trials for the treatment of chronic inflammatory pain.

Gesynta Pharma’s shareholders include Hadean Ventures, Industrifonden, Innovestor Life Science, Linc, HealthCap, XGen Venture, and other internationally renowned specialist investors.

For more information, please visit www.gesynta.se.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/gesynta-pharma/r/first-patient-dosed-in-gesynta-pharma-s-endometriosis-trial-of-vipoglanstat,c4319459

The following files are available for download:

Databricks Launches Genie Code: Bringing Agentic Engineering to Data Work

Genie Code turns data engineering, data science and analytics ideas into autonomous production systems

SAN FRANCISCO, March 11, 2026 /PRNewswire/ — Databricks, the Data and AI company, today launched Genie Code, an autonomous AI agent that fundamentally changes how data work gets done. Genie Code can carry out complex tasks such as building pipelines, debugging failures, shipping dashboards, and maintaining production systems. On real-world data science tasks, Databricks found Genie Code more than doubled the success rate of leading coding agents. Just as agentic coding tools have transformed software engineering, moving developers from autocomplete-style assistance to agent-driven development, Genie Code brings the same paradigm shift to data engineering, data science, and analytics. 

Genie Code is a new addition to Genie, which lets any knowledge worker chat with their data and get trusted answers instantly using the context and semantics captured by Unity Catalog. Genie Code extends this approach to data professionals, handling the complex engineering required to go from idea to production across all enterprise data. Additionally, today Databricks announced the acquisition of Quotient AI, an innovator in evaluation and reinforcement learning for AI agents, to embed continuous evaluation directly into Genie and Genie Code.

Rise of Agentic Data Work
Today’s data tools treat AI as a helper — writing code, running local tests, iterating on it. This leaves data teams doing the hard work of planning, orchestrating, operating, validating and maintaining. Genie Code inverts this approach. It reasons through problems, plans multi-step approaches, writes and validates production-grade code, and maintains the result — all while keeping humans in control of the decisions that matter.

“Software development has shifted from code-assistance to full agentic engineering in the past six months,” said Ali Ghodsi, Co-founder and CEO of Databricks. “Genie Code brings this revolution to data teams. We’re moving from a world where data professionals are assisted by AI to one where AI agents do the work, guided by humans. We are calling this Agentic Data Work. It will fundamentally change how enterprises make decisions.”

What Genie Code Does
Existing agentic coding tools have trouble accomplishing data tasks because they lack access to critical context like lineage, usage patterns and business semantics. Genie Code helps teams bridge the context gap to ensure the high levels of accuracy and governance required for production environments. Genie Code:

  • Acts as an expert machine learning engineer: Genie Code handles full ML workflows end-to-end. It reasons through complex problems to plan, write, and deploy models, while logging experiments to MLflow and fine-tuning serving endpoints for peak performance.
  • Embeds deep data engineering expertise: While a novice engineer might write a script that works on test data, Genie Code designs like a senior architect. It accounts for the differences between staging versus production environments, builds workflows for change data capture and applies data quality expectations.
  • Proactively maintains and optimizes: Genie Code monitors Lakeflow pipelines and AI models in the background to triage failures and investigate anomalies. It autonomously analyzes agent traces to fix hallucinations and tunes resource allocation before a human intervenes.
  • Understands enterprise context: Integrated with Unity Catalog, Genie Code enforces existing governance policies and access controls. It understands business semantics and audit requirements and federates enterprise data, including data from external platforms.
  • Improves over time: Genie Code grows smarter the more teams use it. Through persistent memory, it automatically updates internal instructions based on past interactions and coding preferences. On real-world data science tasks, Databricks found Genie Code more than doubled the success rate of leading coding agents (from 32.1% to 77.1%). 

“At SiriusXM, Genie Code supports everything from authoring notebooks and complex SQL to reasoning through table relationships and debugging pipelines,” said Bernie Graham, VP of Data Engineering, SiriusXM. “It acts as a hands-on development partner that helps our data teams deliver high-quality work in less time.”

“Genie Code changes how our data teams operate,” said Emilio Martín Gallardo, Principal Data Scientist, Data Management & Analytics at Repsol. “Instead of stitching together notebooks, pipelines, and models manually, we can hand off complex workflows to an AI partner that understands our data, governance, business context, and internal libraries such as Repsol Artificial Intelligence Products. It accelerates everything from time series forecasting to production deployment, without sacrificing rigor or control.”

Acquisition of Quotient AI Strengthens Continuous Evaluation
To close the loop on production quality, Databricks has acquired Quotient AI. Quotient automatically monitors agent performance — measuring answer quality, catching regressions early, and pinpointing failures — feeding a reinforcement learning loop that keeps agents improving over time. Quotient’s founders bring deep expertise in evaluating AI coding systems, having previously led quality improvement for GitHub Copilot. By embedding these capabilities into Genie Code, Databricks ensures data and AI systems don’t just run in production, they continuously improve.

About Databricks
Databricks is the Data and AI company. More than 20,000 organizations worldwide — including Adidas, AT&T, Bayer, Block, Mastercard, Rivian, Unilever, and over 60% of the Fortune 500 — rely on Databricks to build and scale data and AI apps, analytics, and agents. Headquartered in San Francisco, Databricks offers a unified Data Intelligence Platform that includes Lakebase, Genie, Agent Bricks, Lakeflow, Lakehouse, and Unity Catalog.

Contact: Press@databricks.com

 

Vertiv’s LATAM Business Receives Frost & Sullivan’s 2025 Latin American Company of the Year Recognition for Leadership in Data Center Infrastructure for AI and HPC

Vertiv Receives Frost & Sullivan’s 2025 Latin American Company of the Year Recognition for Leadership in Data Center Infrastructure for AI and HPC

SAN ANTONIO, March 11, 2026 /PRNewswire/ — Frost & Sullivan is pleased to announce that Vertiv’s LATAM business has been honored with the 2025 Latin American Company of the Year Recognition in the Data Center Infrastructure for AI and HPC industry for its outstanding achievements in innovation, strategy execution, and customer impact. This recognition highlights Vertiv’s consistent leadership in driving measurable outcomes, strengthening its market position, and delivering customer-centric innovation in an evolving competitive landscape shaped by artificial intelligence (AI) and high-performance computing (HPC).

Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: visionary innovation & performance and customer impact. Vertiv excelled in both, demonstrating its ability to align strategic initiatives with market demand while executing them with efficiency, consistency, and scale. “In 2025, Vertiv globally launched its liquid cooling portfolio designed to support AI and high-performance HPC applications, with seamless integration with protected IT equipment and complementary infrastructure. Since 2024, these liquid cooling systems have been provided to regional users, enabling global scaling based on best practices and success cases. The portfolio is the most comprehensive in Latin America, and its proactive digital maintenance is a key differentiator in the market,” said Carina Gonçalves, Industry Principal, Frost & Sullivan.

Guided by a long-term growth strategy focused on digital innovation, localized expansion, and strategic customer collaborations, Vertiv has shown its ability to adapt and lead in a rapidly evolving AI-driven landscape. As AI workloads push rack densities beyond 30 kW and up to 120 kW or more, the company has invested significantly in advanced power and thermal management technologies, hybrid modular designs, and services to meet the needs of hyperscale and colocation data centers across Latin America.

Innovation remains central to Vertiv’s approach. Its comprehensive portfolio of critical digital infrastructure solutions—including heat exchangers, cooling distribution units (CDUs), prefabricated modular power and cooling blocks, and remote monitoring and management platforms—addresses the full spectrum of AI and HPC deployment requirements. From installation and commissioning to lifecycle services, fluid management, and proactive digital maintenance, Vertiv delivers scalable, energy-efficient solutions that improve power usage effectiveness (PUE) and water use efficiency (WUE). “This recognition reflects the rapid evolution of AI infrastructure across Latin America and the growing need for resilient, high-performance digital infrastructure,” said Alex Sasaki, Sales Vice President for Vertiv Latin America. “Our focus is to help organizations in the region deploy scalable power and cooling solutions that support the next generation of AI and high-performance computing.”

Vertiv’s unwavering commitment to customer experience further strengthens its position in the market. The company supports customers through more than 240 service centers globally, over 3,500 field engineers, and 190 technical response specialists. In Latin America, Vertiv has reinforced its regional footprint through strategic contracts and localized investments, including a landmark agreements wlocal data center providers to pioneer liquid-cooling systems for hyperdense AI applications. With local Vertiv sales teams and channel-led delivery model, localized service hubs in Colombia, Mexico, Chile, and Peru, and the launch of Vertiv Academy Latin America underscore its focus on knowledge transfer, operational excellence, and long-term customer value.

Frost & Sullivan commends Vertiv for setting a high standard in competitive strategy, execution, and response to the needs of the regional markets. The company’s vision, innovation pipeline, and customer-first culture are shaping the future of data center infrastructure for AI and HPC and driving tangible results at scale.

Each year, Frost & Sullivan presents the Company of the Year Award to a company that demonstrates outstanding strategy development and implementation, resulting in measurable improvements in market share, customer satisfaction, and competitive positioning. It recognizes forward-thinking organizations that are reshaping their industries through innovation and growth excellence.

Frost & Sullivan Best Practices Recognition

Frost & Sullivan’s Best Practices Recognitions honor companies across regional and global markets that exhibit exceptional achievement and consistent excellence in areas such as leadership, technological innovation, customer experience, and strategic product development. Each recognition is the result of a rigorous analytical process in which Frost & Sullivan industry experts benchmark performance through comprehensive interviews, deep-dive analysis, and extensive secondary research. The goal is to identify true best-in-class organizations that are driving transformative growth and setting new industry standards.
Contact us: Start the discussion.

Contact:
Ashley Shreve
E: ashley.weinkauf@frost.com

Embedded world 2026 | Leading the Pet Tech Revolution: MQ771-GL Redefines Smart Pet Collars

NUREMBERG, Germany, March 11, 2026 /PRNewswire/ — As pet owners increasingly pursue data-driven and scientific pet care, pet collars are evolving beyond simple identification tools into intelligent devices integrating positioning, health monitoring, and behavior analysis.

Fibocom Pet Collar Solution
Fibocom Pet Collar Solution

Fibocom’s MQ771-GL addresses the demanding requirements of this vertical market with multiple key advantages.

Ultra-Low Power in a Compact Design: Ending Battery Life Anxiety

For pet owners, size and power consumption remain the biggest challenges for smart collars. The MQ771-GL is deeply optimized in both aspects.

  • Ultra-compact form factor (17.7 mm × 15.8 mm) enables manufacturers to maximize device design flexibility.
  • PSM current as low as 1 μA significantly reduces power consumption during deep sleep, delivering 70–90% improvement compared with the previous generation.
  • eDRX technology dramatically lowers standby current, ensuring extremely low power consumption when the collar is idle. In real-world scenarios, device battery life can be extended from days to several months, enabling long-lasting companionship for pets.

Global Connectivity: Keeping Pets Connected Everywhere

The MQ771-GL supports global Cat.M / NB-IoT frequency bands, ensuring reliable connectivity across regions.

  • Multi-mode network switching allows the module to automatically select the optimal network whether pets are in dense urban areas, remote outdoor environments, or even traveling internationally.

Comprehensive Health Monitoring and Behavior Insights

With strong processing capabilities, MQ771-GL supports integration of multiple sensors, enabling developers to build advanced monitoring features.

  • Behavior analysis: accurately detects barking patterns and activity frequency.
  • Physiological monitoring: supports efficient transmission of heart rate and respiratory data, enabling data-model analysis of sleep quality and early detection of potential health issues.

Sunzhi Liu, General Manager of Wireless Communications at Fibocom, commented:

“MQ771-GL represents a milestone product in our LPWA portfolio. By combining Qualcomm’s advanced chipset capabilities with Fibocom’s extensive communication expertise, we aim to deliver a highly integrated, cost-effective, and high-performance platform for the pet technology market. We look forward to collaborating with more partners to further expand the pet tech ecosystem.”

About Fibocom

Fibocom, founded in 1999, is China’s first wireless communication module company listed on both the A-share and H-share markets (300638.SZ, 0638.HK). As a global leading provider of wireless communication modules and AI solutions, Fibocom leverages wireless communication and artificial intelligence as its core technologies to provide integrated hardware and software solutions that empower industry applications. These solutions accelerate the transformation from “Connect Everything” to “Intelligent Connectivity” across diverse industries.

Fibocom’s one-stop solutions encompass cellular communication, AI, automotive, and GNSS modules, as well as AI toolchains, supporting industry-side and mainstream large model integration, and providing AI Agent, global connectivity, and cloud services, driving the digital intelligence upgrades in industries such as robotics, consumer electronics, low-altitude economy, intelligent transportation, smart retail, and smart energy.

 

IotaMotion Strengthens Leadership Position in Robotic Cochlear Implant Surgery with Issuance of New U.S. Patent

ST. PAUL, Minn., March 11, 2026 /PRNewswire/ — iotaMotion, Inc., the leader in robotic-assisted insertion systems for cochlear implantation and creator of iotaSOFT®, the first and only FDA cleared robotic-assisted cochlear implant insertion system, today announced the issuance of U.S. Patent No. 12,558,123, further strengthening its intellectual property portfolio in robotic-assisted cochlear implantation.

The iotaSOFT® Robotic-Assisted Cochlear Implant Insertion System enables slow, consistent and controlled electrode insertion to preserve delicate intracochlear structures. FDA cleared for patients four years and older, the system addresses a major unmet need, as fewer than 5% of the 60 million people worldwide who could benefit from cochlear implants receive them.
The iotaSOFT® Robotic-Assisted Cochlear Implant Insertion System enables slow, consistent and controlled electrode insertion to preserve delicate intracochlear structures. FDA cleared for patients four years and older, the system addresses a major unmet need, as fewer than 5% of the 60 million people worldwide who could benefit from cochlear implants receive them.

“This new patent augments our strong intellectual property portfolio, which broadly covers systems and methods related to robotic positioning and control in cochlear implant surgery,” said Mike Lobinsky, CEO of iotaMotion. “As iotaSOFT becomes increasingly integrated across leading cochlear implant centers, protecting the technologies that standardize and control electrode insertion is central to sustaining our leadership in the field.”

The iotaSOFT Insertion System advances surgery beyond the limits of the human hand with consistent and controlled electrode insertion that preserves delicate intracochlear structures. The system is FDA cleared for patients four years of age and older and is commercially available in the United States.

According to the World Health Organization, more than 430 million people globally experience disabling hearing loss, including over 60 million individuals who may benefit from cochlear implantation, yet fewer than 5% of eligible patients worldwide receive an implant. As robotic-assisted technology continues to gain clinical adoption, intellectual property strength plays a critical role in enabling sustained innovation and long-term advancement within the field.

About iotaMotion

iotaMotion, Inc. is a medical technology company based in St. Paul, Minnesota, focused on advancing cochlear implant surgery beyond human capability through robotic-assisted innovation. Its flagship technology, the iotaSOFT® Insertion System, is designed to preserve delicate intracochlear structures through a slow and consistent electrode array insertion. The system is FDA cleared for patients four years of age and older and is commercially available in the United States, with clinical investigation underway in other global markets.

For more information, visit www.iotamotion.com and follow us on LinkedIn, X, Facebook, YouTube.

Media Contact:
Holly Windler
hwindler@iotamotion.com
619.929.1275

iotaMotion— the leader in robotic-assisted insertion systems for cochlear implantation and maker of the iotaSOFT® Insertion System, the first and only FDA market authorized robotic-assisted insertion system, indicated for patients four years and older.
iotaMotion— the leader in robotic-assisted insertion systems for cochlear implantation and maker of the iotaSOFT® Insertion System, the first and only FDA market authorized robotic-assisted insertion system, indicated for patients four years and older.

 

Comviva Launches NGAGE for Enterprises to Power Secure, AI-Driven Customer Engagement at Scale

– Next-generation CPaaS platform that integrates omnichannel communication, network-based identity, and conversational AI to help enterprises deliver trusted digital experiences

LAS VEGAS and NEW DELHI, March 11, 2026 /PRNewswire/ — Comviva, a global leader in digital transformation solutions across customer experience management, data monetization, and digital financial services, today announced the launch of NGAGE for Enterprises, a next-generation CPaaS platform designed to help enterprises deliver seamless, secure, and intelligent customer experiences at scale.

Unveiled ahead of Enterprise Connect 2026, NGAGE for Enterprises empowers organizations to orchestrate meaningful customer journeys across every digital touchpoint—while embedding trust, identity, and fraud protection directly into the engagement layer. The platform combines omnichannel communications, network-based identity intelligence, AI-driven automation, and resilient global connectivity within a unified SaaS environment—helping enterprises simplify operations, accelerate deployment, and improve customer experience.

Speaking on the launch, Deshbandhu Bansal, Chief Operating Officer for the RevTech Solutions at Comviva, said, “As enterprises scale digital engagement, they are also confronting rising fraud risks, fragmented communication infrastructure, and growing pressure to deliver personalized experiences. NGAGE for Enterprises addresses these challenges by bringing together communications, identity intelligence, and AI automation into a single unified SaaS platform—enabling organizations to build trusted, scalable, and cost-efficient customer engagement journeys.”

The platform enables enterprises to design and deploy intelligent customer journeys through an intuitive low-code workflow builder. Organizations can create personalized, context-aware interactions across service, support, marketing, and lifecycle engagement.

NGAGE supports engagement across channels including SMS, Email, RCS, and WhatsApp, while also enabling enterprises to leverage network-based identity services such as phone number verification and SIM check to strengthen security and reduce fraud.

The SaaS-based platform also offers transparent billing and real-time performance visibility, allowing enterprises to manage and optimize customer engagement strategies across regions while controlling costs.

NGAGE builds on Comviva’s established communications infrastructure, which currently supports deployments across more than 200 countries and is trusted by over 7,000 enterprises and 100+ telecom operators worldwide.

NGAGE consolidates enterprise onboarding, configurable journey orchestration, omnichannel engagement, fraud management, and real-time usage monitoring within a unified architecture.

Built for interoperability, the platform supports TMF931 for enterprise and application lifecycle management and aligns with TM Forum Open APIs and CAMARA standards—enabling telcos to participate in aggregator ecosystems, expand go-to-market channels, and seamlessly connect enterprises to network capabilities.

 

NYSE Content Update: United States Antimony Corp. Rings Bell to Mark its Listing

NYSE issues a pre-market daily advisory direct from the trading floor.

NEW YORK, March 11, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

 

Entrepreneurs First to join Taking Stock after the market close

Kristen Scholer delivers the pre-market update on March 11th

  • Equities remain choppy as the conflict in the Middle East continues and the International Energy Agency is proposing the biggest-in-history release of emergency oil reserves.
  • Inc. unveiled its 2026 Female Founders 500 list yesterday, honoring dynamic women business leaders.
  • Entrepreneurs First announced earlier that it raised $200 million to support the next generation of builders, with contributions from investors including Reid Hoffman and Eric Schmidt.
  • U.S. Antimony (NYSE: UAMY) Chairman and CEO Gary Evans will join NYSE Live this morning to explain the company’s critical role in defense applications.  

Opening Bell
U.S. Antimony (NYSE: UAMY) celebrates its uplisting to the NYSE

Closing Bell
Costamare Bulkers (NYSE: CMDB) celebrates its 2025 spin-off

For market insights, IPO activity, and today’s opening bell, download the NYSE TV App: TV.NYSE.com

Bunge CEO Greg Heckman hosted its investor day at NYSE
Bunge CEO Greg Heckman hosted its investor day at NYSE

 

 

 

Skydream to Make Its Silicon Valley Debut, Showcasing Next Generation RV Technology

SAN JOSE, Calif., March 11, 2026 /PRNewswire/ — Skydream, a next-generation intelligent RV brand, will make its official U.S. debut at a special launch event on Monday, March 23, 2026, in San Jose, California. The event will offer an exclusive first look at the Skydream Intelligent travel trailer, along with the company’s pioneering technologies.

“RV culture represents one of the most powerful expressions of freedom worldwide, and Skydream is excited to enhance that freedom with our next-generation Intelligent RV,” said Felix Yang, founder and CEO of Skydream. “Skydream was designed for travelers who don’t want to choose between adventure and modern living.”

Skydream’s U.S. debut caps a momentous year of global engagement. Since its international premiere at the world’s largest RV trade fair, Caravan Salon Düsseldorf, in August 2025, Skydream has built momentum quickly, establishing dealer partnerships, and earning the Platinum Award at the 2025 MUSE Design Awards.

At the Silicon Valley event, Skydream will introduce its range of pioneering technologies, including its self-developed native integrated intelligent platform. Skydream’s platform is built around three core capabilities. Intelligent Living features a cabin that adapts through scenario-based modes, with whole-cabin voice control and a modular interior system. Intelligent Mobility reduces towing stress through one-touch leveling, active stability control and automated parking assistance. Intelligent Energy enables 14 days of fully off-grid living thanks to a high-capacity lithium iron phosphate (LFP) battery system and up to 2,200 watts of integrated solar power.

At the March 23 event, guests will experience the RV trailer firsthand, hear from company leadership about Skydream’s North American strategy, and explore dealer partnership opportunities. The company is targeting its first U.S. deliveries for December 2026.